Tailored antibody-drug conjugate offers hope for aggressive breast cancer

FHS
May 22, 2024
3:48 am

Scientists have used breast cancer cells’ weakness against themselves by linking a tumour-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.

Specialised Therapeutics partners Treeway to license ALS drug

TW001 is intended for the treatment of amyotrophic lateral sclerosis. Credit: Green Apple/Shutterstock.com. Specialised Therapeutics (ST) has entered into a licensing agreement with Dutch biotech

August 28, 2023

Aerobic glycolysis essential for eye development in mammals, study finds

Aerobic glycolysis, the process by which cells transform glucose into lactate, is key for eye development in mammals, according to a new Northwestern Medicine study

July 15, 2023

Philanthropic endowments at universities can offer a way out of biotech’s Valley of Death

So many promising medical innovations never reach their full potential as therapies or cures, languishing instead in a metaphoric place many of us in biotech

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.